Snowball logo
logo
A71_logo

Ascendis Pharma AS

€198.00+€3.00  (1.54%)
Estimate
EPS
-3.77
Beta
0.485
About the company
Ticker
A71
ISIN
US04351P1012
Country
Denmark
Sector (GICS)
Healthcare
Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally. The company offers SKYTROFA for treating pediatric patients with growth hormone deficiency; and YORVIPATH, a once-daily subcutaneous injection for the treatment of adults with chronic hypoparathyroidism. It is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is based in Hellerup, Denmark.

Frequently asked questions

What sector does Ascendis Pharma AS (A71) operate in?

Ascendis Pharma AS belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Ascendis Pharma AS (A71) current stock price?

As of the latest data, Ascendis Pharma AS stock price is €198.00, with a previous close of €195.00. Ascendis Pharma AS gained €3.00 in the last trading session, representing a 1.54% increase.

What is Ascendis Pharma AS (A71) current market capitalization?

Ascendis Pharma AS market cap is approximately 12.16 billion.

What is Ascendis Pharma AS (A71) Earnings Per Share (EPS)?

The trailing EPS is -€3.77.

Does Ascendis Pharma AS (A71) pay dividends?

No. Ascendis Pharma AS does not pay a dividend.

What is Ascendis Pharma AS (A71) beta (volatility) score?

Ascendis Pharma AS has a beta of 0.485, indicating lower volatility than the overall market.